Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Medulloblastoma is an embryonal childhood malignancy with poor prognosis. By screening 4 medulloblastoma cDNA expression libraries (SEREX) with autologous sera, 15 different antigens were identified. These antigens were encoded by 3 novel genes, genes of unknown function (KIAA0445, KIAA1853, KIAA0665, FLJ13942, HSPC213), a proto‐oncogene (rab18), candidate tumor suppressor genes (BAP1, PRDM13) and genes encoding a motor protein (kinesin‐2), a histone (H2A1.2), the ankyrin residue‐rich nasopharyngeal cancer susceptibility protein (NZ16) and the transcription factor TZP, which is homologous to the tumor‐associated antigens HCA58 and GLEA2. In a consecutive analysis of serum antibody titers and tumor load, a more than 10‐fold increase in serum antibodies against PRDM13 preceded the clinical diagnosis of recurrent tumor growth in a patient with aggressive large cell medulloblastoma. When sera of pediatric patients with cancer (n = 40) and healthy controls (n = 40) were tested for humoral responses against the SEREX‐defined antigens, 5 antigens were exclusively recognized by sera from cancer patients. These antigens included a novel rab18 gene product translated from mRNA sequences formerly described as 3′ untranslated region. Humoral responses against 2 of the remaining 10 antigens were found preferentially in cancer patients. Antibodies against these antigens were detected in 8/40 and 12/40 cancer patients, respectively, but in only 1 healthy control. The 2 antigens were characterized by a tumor‐specific deletion and a tumor‐specific mutation, respectively. These findings indicate that the humoral immune response against medulloblastoma is directed against diverse antigens that may be useful as diagnostic markers or targets for immunotherapy. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two Kinesin Light Chain Genes in Mice
Rahman, A., Friedman, D. S., & Goldstein, L. S. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15395 · Cited by 123
Cited by
Tudor, MBT and chromo domains gauge the degree of lysine methylation
Kim, J., Daniel, J., Espejo, A., Lake, A., Krishna, M., Xia, L., Zhang, Y., & Bedford, M. T. (2006) · EMBO reports · doi:10.1038/sj.embor.7400625 · Cited by 492
Integrin Trafficking and the Control of Cell Migration
Caswell, P. T., & Norman, J. C. (2006) · Traffic · doi:10.1111/j.1600-0854.2005.00362.x · Cited by 353
The prdm family: expanding roles in stem cells and development
Hohenauer, T., & Moore, A. W. (2012) · Development · doi:10.1242/dev.070110 · Cited by 265
“In addition, Prdm13 is a tumour antigen associated with medulloblastoma (Behrends et al., 2003).”
BackgroundCalarco, J. A., Superina, S., O'Hanlon, D., Gabut, M., Raj, B., Pan, Q., Skalska, U., Clarke, L., Gelinas, D., van der Kooy, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.012 · Cited by 225
PRDM proteins: important players in differentiation and disease
Fog, C. K., Galli, G. G., & Lund, A. H. (2012) · BioEssays · doi:10.1002/bies.201100107 · Cited by 201
“Interestingly, PRDM13 was identified as a tumor antigen of medulloblastoma, a brain tumor malignancy deriving from embryonal cells of neuroectodermal origin [38].”
Background
Metadata
- Authors
- Behrends, U., Schneider, I., Rössler, S., Frauenknecht, H., Golbeck, A., Lechner, B., Eigenstetter, G., Zobywalski, C., Müller‐Weihrich, S., Graubner, U., Schmid, I., Sackerer, D., Späth, M., Goetz, C., Prantl, F., Asmuss, H., Bise, K., & Mautner, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-05-14
- Volume
- 106
- Issue
- 2
- Pages
- 244-251
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2091417442
- Cited by
- 54
- References
- 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. https://app.cochat.ai/papers/10.1002/ijc.11208
- The paper
- Behrends, U., Schneider, I., Rössler, S., Frauenknecht, H., Golbeck, A., Lechner, B., Eigenstetter, G., Zobywalski, C., Müller‐Weihrich, S., Graubner, U., Schmid, I., Sackerer, D., Späth, M., Goetz, C., Prantl, F., Asmuss, H., Bise, K., & Mautner, J. (2003). Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. International Journal of Cancer. https://doi.org/10.1002/ijc.11208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.